Isodiol International Inc (ISOLF)

[Sellig]

Isodiol International Inc. Announces Binding Agreement to Acquire Biosynthesis Pharma Group

C.ISOL | 13 hours ago

VANCOUVER, British Columbia, Dec. 17, 2017 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that the Company has entered into a binding agreement to acquire the Biosynthesis Pharma Group (BSPG), an industry leading producer of industrial hemp, it’s derivatives and pharmaceutical compounds for use in the medicinal, nutraceutical, food and cosmetic industries.


Read more at http://www.stockhouse.com/news/press-releases/2017/12/17/isodiol-international-inc-announces-binding-agreement-to-acquirebiosynthesis#xVGP7HC8BzZkXC56.99